Member Info for Tyke68

I found the video, weeks equals months and months equals year.

I wonder if this paper is a follow up to this video after further trials or this paper relates to this trial?

https://youtu.be/AGiFpbAh-Yo?feature=shared

About 10 minutes in

Thanks

Can anybody remember the multiplier for people compared to animals in time scale that was quoted in a video. Because 6 months in an animal is a lot longer in humans I believe.

Thanks Shrek/max

As always please keep digging. I will write your references for TB to give you a job.

Thanks

Kane

I think this is what semantic was saying about being the only way to communicate with possible customers/users etc.

It is not intended for shareholders but I agree the paediatric one should be RNSed

It is just Max, Shrek et al that find this through their detective work, who is Holmes and whom is Watson?

Thanks

Interesting Max your article is from OUP. Spreading the word to Europe hopefully.

Thanks

Thanks Shrek

Are we targeting the wrong people?

If the oncology and radiology are so busy then should we be speaking to the hospital managers etc and say this how we could help your staff and reduce their workload.

Just trying to think of ways to get our tech out there. We haven’t heard any more about GEHC, Bayer/blackford, prism. Were we hoping one of them would buy the tech side to finance the IB003 trial?

Just knocking ideas about

Have a good weekend

Thanks

Semantic

Fair point so what could IB do to get their tech sold more if previous partnerships have failed with increasing revenue. The step fold changes and 40+ leads didn’t create the momentum as the company had hoped. We have been going to conferences for years and if I remember correctly didn’t win an award in 2019 and that didn’t significantly increase revenue.

It seems we need to get a bigger foothold somehow.

Thanks

Thanks Max

AM seems really quiet at the moment. We all hoped he would be very vocal for IB especially its imaging tech. We could really do with him highlighting our tech.

Here’s a question, do we actually have a marketing team or sales reps knocking on doors?

I know I asked before but it was assumed our partnerships would do the selling but obviously that hasn’t turned out as hoped. Let people have a free trial to see how good the product is etc build some momentum etc.

Thanks

Max

Like somebody said previously you and Phil should be doing PR for company.

TB/semantic we need people plugging this here there and everywhere not just 118 views on twitter.

Can we get it in journals etc please?

Thanks

Might not get chance to say this tomorrow. So have a good weekend everybody and we all have a better week next week on the IBAI rollercoaster.

Thanks

Could these be tempted to make a bid for our tech?

https://www.businessinsider.com/abridge-wants-to-buy-healthcare-ai-startups-2025-8

Thanks

Mallettp

I am guessing as it is a niche market the actual sale price of an approved drug would be quite high. Plus the vouchers would more than compensate a successful drugs development.

Thanks

D-Geeman

I think the issue (just my understanding) is more the rigmarole the hospital clinic have to do to get their site registered so they can administer the EAP to patients. Cost and time involved. The patients want it but need a site which will administer and supervise it.

Thanks

Rereading the RNS

Positives

•Net assets has increased by £200k in 6 months

•phase 1 of IB003 “The trial met its primary endpoints, with early data suggesting a potentially superior therapeutic profile relative to current standard-of-care.”

•Paediatric vouchers may still be possible circa $100m each

•IB Clinic, finally realised the need to direct sell to clinicians which some of us have been asking for for quite a while now

•IB ASL up and running, hopefully that is sold directly as well

•IB Nimble improvements

•The board acknowledges the shareholders frustration with the share price.

Negatives

•Less revenue but now acknowledged a change in how they need to sell their products is required

•EAP issues of access but looking into this. We need this for the real world data aspect.

•No mention of the GAM patent application

•No mention of the new website

No plan/commitment to try and increase the sp in the short term

Like The_Paladin stated I think this is a very honest update and states exactly where we are at.

People need to consider all the facts and decide whether to sell, hold or buy more. I will be holding. Personally I think we may be seeing more positive RNS’s in the near future (by Christmas) to placate shareholders and insiders.

Good luck whatever you decide

Thanks

If you look at the news article headline. It says losses narrow. If you add that to IB tech being mentioned as one to note a few days ago then people could maybe start seeing the potential and how seriously undervalued we are. We can but hope.

Thanks

Cautious

I could come on here whinging etc (I have done that previously) but it would make no difference. If I had spent what I have previously (and now show as a paper loss) I would have over 10m shares and be classed as a significant shareholder. I don’t because I still believe in the company.

You seem to take my positivity as making excuses for TB. I most definitely am not. I would like to think this comes good for the patients first and then shareholder value follows. Health before wealth.

Thanks

Cautious

I have already commented on TB wages and said I would prefer it if was targeted and based on the sp.

Thanks

Max

Just don’t go buying lottery tickets. With your luck you will get no numbers.

Thanks

Max

I am beginning to think you didn’t get the decimal point in the wrong place. Maybe you were foreseeing how low this could go.

Thanks

Cautious

As always it can be viewed in a positive or negative manner depending on your perspective

Major negatives is that revenue is down, sales has not been as hoped

Major positives: we almost made a profit, the vouchers are still within our grasp, the company strategy seems to be changing to as they realise sales have not been what they hoped. Phase 1 is progressing to phase 2.

I am sure you will say I am supporting TB again but I am just looking at both sides of the argument. As you say you have a choice, sell or hold. It is up to investors to decide which is best for them.

Thanks